Hester Biosciences Ltd
NSE:HESTERBIO

Watchlist Manager
Hester Biosciences Ltd Logo
Hester Biosciences Ltd
NSE:HESTERBIO
Watchlist
Price: 2 403.9 INR 0.92% Market Closed
Market Cap: 20.4B INR
Have any thoughts about
Hester Biosciences Ltd?
Write Note

Operating Margin
Hester Biosciences Ltd

15.1%
Current
14%
Average
-7.8%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
15.1%
=
Operating Profit
470.6m
/
Revenue
3.1B

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
IN
Hester Biosciences Ltd
NSE:HESTERBIO
20.4B INR
15%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
316.5B USD
28%
US
Amgen Inc
NASDAQ:AMGN
141.2B USD
19%
US
Gilead Sciences Inc
NASDAQ:GILD
117.1B USD
38%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
105.3B USD
40%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
AU
CSL Ltd
ASX:CSL
135.7B AUD
26%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.2B USD
30%
US
Seagen Inc
F:SGT
39.3B EUR
-33%
NL
argenx SE
XBRU:ARGX
36B EUR
-22%
Country IN
Market Cap 20.4B INR
Operating Margin
15%
Country FR
Market Cap 6T USD
Operating Margin
-17 527%
Country US
Market Cap 316.5B USD
Operating Margin
28%
Country US
Market Cap 141.2B USD
Operating Margin
19%
Country US
Market Cap 117.1B USD
Operating Margin
38%
Country US
Market Cap 105.3B USD
Operating Margin
40%
Country US
Market Cap 94.1B EUR
Operating Margin
-370%
Country AU
Market Cap 135.7B AUD
Operating Margin
26%
Country US
Market Cap 78.2B USD
Operating Margin
30%
Country US
Market Cap 39.3B EUR
Operating Margin
-33%
Country NL
Market Cap 36B EUR
Operating Margin
-22%
No Stocks Found

Hester Biosciences Ltd
Glance View

Market Cap
20.4B INR
Industry
Biotechnology

Hester Biosciences Ltd. is a holding company, which engages in the manufacture and trade of poultry vaccines and animal health products. The company is headquartered in Ahmedabad, Gujarat and currently employs 584 full-time employees. Its segments include Poultry division and Animal division. The company provides over 40 products across poultry vaccines (live and inactivated), animal vaccines (live and inactivated), health products and diagnostics. Its product range includes vaccines, drugs, feed supplements and disinfectants. The company manufactures over two live vaccines for large animals, including Peste des Petits Ruminants (PPR) Live vaccines and Goat Pox Vaccine. Its offerings include Avian, including Live B1, Live LAS, Live R2B, Live M48, Live FP, Gumboro M1, Gumboro I and Gumboro I+; swine fever vaccines, and animal, including PPR Vaccine-Sungri 96 strain and Brucella abortus (S19) calf Vaccine. The company offers services, such as seromonitoring for poultry farms and mastitis prevention programs for cattle farms.

HESTERBIO Intrinsic Value
1 593.33 INR
Overvaluation 34%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
15.1%
=
Operating Profit
470.6m
/
Revenue
3.1B
What is the Operating Margin of Hester Biosciences Ltd?

Based on Hester Biosciences Ltd's most recent financial statements, the company has Operating Margin of 15.1%.